Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by barcodewhizon Feb 06, 2007 2:00am
261 Views
Post# 12168809

RE: Delay-Delay-Delay....

RE: Delay-Delay-Delay.... I hear ya Stoocks... TWO THINGS : you have been in this long enough to know that HMSL / Catalyst has nothing to do with PLI's therapeutic drug pipleline...or saving lives. PLI's Cascade proces is about plasma fractionation efficiency... Second, I was making the point that I LIKE all of the negative sentiment around this... because it is so COMPLETELY opposite my take on the situation. From a stock sentiment / valuation perspective, this tells me this stock is NOT overbought... and has lots of room to run when the true future of the PLI / Catalyst ( Melnyk ) becomes clear. IMHO, the market is continuing to substantially undervalue the likelihood and significance of this situation resolving itself substantially in PLI's favour.
Bullboard Posts